Invesaro

Stocks ARRY Financial statements

Financial statements

Array Technologies, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Array Technologies, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Revenue2916488738531,6381,5779161,284
Cost of revenue2794976707851,4251,161618986
Gross profit11.615120368.3213416298299
Research and development4.28.56.79.9
General and administrative46.941.255.681151160161199
Operating expenses72.867.410893231201525328
Operating income-61.283.495.2-24.7-18.1214-227-29
Interest expense1918.815.135.736.744.234.827.3
Other non-operating income-19.5-18.8-17.4-36.413.2-37-23.6-0.22
Pre-tax income-80.764.677.8-61.1-4.95177-251-29.2
Income tax-19.924.818.7-10.7-9.3839.9-10.223
Net income-60.839.759.1-50.44.43137-240-52.2
EBITDA-32.81111231.2182.9253-191-2.8
EPS, basic-0.510.330.49-0.51-0.290.57-1.95-0.73
EPS, diluted-0.510.330.49-0.51-0.290.56-1.95-0.73
Shares, basic (weighted)120120121130150151152153
Shares, diluted (weighted)120120122130150152152153

Balance sheet

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents40.8310108368134249363244
Receivables96.3119236421332276272
Inventory148118206233162201150
Other current assets13.512.433.639.489.127.821.8
Total current assets620375852831832999869
Property, plant and equipment10.79.7710.723.227.926.258.2
Lease right-of-use assets11.217.822.116.448.3
Goodwill69.769.769.7416436160135
Intangible assets224198175386354181239
Other non-current assets03.0926.432.740.725.329.7
Total assets9246561,1431,7061,7071,4261,452
Accounts payable13082.892170119172144
Accrued liabilities11.515.813.154.3
Deferred revenue32915099.617966.5120128
Short-term debt55.94.314.338.721.530.710.3
Total current liabilities591289245465336438377
Long-term debt0424711720661647659
Lease liabilities5.3613.919.515.147.3
Other non-current liabilities05.5614.820.43.569.04
Total liabilities6187379751,2821,0961,1371,191
Total debt55.9428715759682677669
Paid-in capital140203383345298227
Retained earnings-221-272-267-130-371-423
Other comprehensive income08.4344.8-45.4-10.5
Shareholders' equity305-80.9-69.2124259-118-206
Total equity305-80.9-69.2124259-118-206
Total liabilities and equity9246561,1431,7061,7071,4261,452

Cash flow statement

FY2018FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Net income-60.839.759.1-50.44.43137-240-52.2
Depreciation and amortization28.527.327.525.910138.936.126.2
Stock-based compensation00.84.8113.81514.510.315.6
Deferred income tax-20.122.3-2.74-10.1-31.6-8.86-37.73.2
Change in receivables19.4-40.7-23-117-7792.841.431
Change in inventory-10.3-94.628.3-88.220.966.7-44.852.9
Cash from operations-11.7386-122-263141232154102
Capital expenditures-2.07-1.7-1.34-3.36-10.6-17-7.31-22
Acquisitions00-37400-165
Purchases of investments-1200
Cash from investing-6.43-1.7-1.34-15.3-384-16.8-9.57-188
Stock issued014612115.900
Cash from financing50.9-63.9-1295388.44-102-11.8-38.1
Exchange rate effect000.741.81-17.56
Net change in cash32.7320-253259-234115115-118
Free cash flow-13.8384-124-26713121514779.8
Interest paid14.311.36.9424.323.143.938.716.1
Income taxes paid0.180.4431.113.310.745.92823.3

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.03 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin24.3%Gross profit / revenue.
Operating margin-5.1%Operating income / revenue.
EBITDA margin-2.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-6.2%Pre-tax income / revenue.
Net margin-7.2%Net income / revenue.
FCF margin11.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin13.7%Cash from operations / revenue.
Return on assets (ROA)-5.6%Net income / average total assets.
Return on invested capital (ROIC)-32.4%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue1.1%Research and development expense / revenue.
Stock-based pay / revenue1.5%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.4%Capital expenditures / revenue.
D&A / revenue2.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y40.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-7.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y8.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y0.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y12.0%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y8.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-33.9%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-10.4%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y-45.6%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-15.2%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y1.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-5.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y17.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.6%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y4.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.20xCurrent assets / current liabilities.
Quick ratio1.55x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.76x(Cash + short-term investments) / current liabilities.
Debt / assets42.9%Total debt / total assets.
Liabilities / assets80.7%Total liabilities / total assets.
Net debt$350.4MTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-2.78xOperating income / interest expense.
Working capital$486.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets22.7%(Goodwill + intangible assets) / total assets.
Tangible book value-$549.7MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.77xRevenue / average total assets.
Fixed asset turnover17.4xRevenue / average property, plant and equipment.
Inventory turnover5.74xCost of revenue / average inventory.
Days inventory64 days365 x average inventory / cost of revenue.
Receivables turnover3.66xRevenue / average receivables.
Days sales outstanding100 days365 x average receivables / revenue.
Days payables66 days365 x average accounts payable / cost of revenue.
Cash conversion cycle98 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow17.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.55Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$7.61Revenue / diluted weighted shares.
FCF per share$0.87Free cash flow / diluted weighted shares.
Operating cash flow per share$1.05Cash from operations / diluted weighted shares.
Book value per share-$1.30Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$3.53Tangible book value / shares outstanding.
Cash per share$1.97(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$620.7MShare price x shares outstanding.
Enterprise value$971.1MMarket cap + total debt - cash - short-term investments.
P/S0.52xMarket cap / revenue.
P/FCF4.61xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF3.81xMarket cap / cash from operations, when positive.
EV/Sales0.82xEnterprise value / revenue.
EV/FCF7.21xEnterprise value / free cash flow, when both are positive.
FCF yield21.7%Free cash flow / market cap.
Earnings yield-13.8%Net income / market cap (the inverse of P/E).
What was Array Technologies, Inc.'s revenue in fiscal 2025?

Array Technologies, Inc. reported revenue of $1.28B for fiscal 2025, 40.2% higher than the year before.

Was Array Technologies, Inc. profitable in fiscal 2025?

No. It reported a net loss of $52.2M.

How much free cash flow did Array Technologies, Inc. generate in fiscal 2025?

Cash from operations of $101.8M minus capital expenditures of $22.0M left free cash flow of $79.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Array Technologies, Inc.